Markus Renschler
2021
In 2021, Markus Renschler earned a total compensation of $3.5M as President and Chief Executive Officer at Cyteir Therapeutics, a 376% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $227,516 |
|---|---|
| Option Awards | $2,775,397 |
| Salary | $503,841 |
| Total | $3,506,754 |
Renschler received $2.8M in option awards, accounting for 79% of the total pay in 2021.
Renschler also received $227.5K in non-equity incentive plan and $503.8K in salary.
Rankings
In 2021, Markus Renschler's compensation ranked 3,819th out of 12,415 executives tracked by ExecPay. In other words, Renschler earned more than 69.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,819 out of 12,415 | 69th |
Division Manufacturing | 1,563 out of 5,505 | 72nd |
Major group Chemicals And Allied Products | 636 out of 2,375 | 73rd |
Industry group Drugs | 565 out of 2,096 | 73rd |
Industry Pharmaceutical Preparations | 395 out of 1,546 | 75th |
Source: SEC filing on April 29, 2022.
Renschler's colleagues
We found two more compensation records of executives who worked with Markus Renschler at Cyteir Therapeutics in 2021.